{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:03:23Z","timestamp":1740107003503,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00520-022-07434-3","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T09:02:41Z","timestamp":1667293361000},"page":"9693-9695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Response to: Prognosis of metastatic bone cancer and myeloma patients and long\u2011term risk of medication\u2011related osteonecrosis of the jaw (MRONJ): some critical points"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0077-7026","authenticated-orcid":false,"given":"Hironobu","family":"Hata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1090-3660","authenticated-orcid":false,"given":"Kenji","family":"Imamachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8199-3037","authenticated-orcid":false,"given":"Masashi","family":"Matsuzaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Hiraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0220-0535","authenticated-orcid":false,"given":"Toshihisa","family":"Osanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Harabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Oizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6641-9598","authenticated-orcid":false,"given":"Masato","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"key":"7434_CR1","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1007\/s00520-022-06839-4","volume":"30","author":"H Hata","year":"2022","unstructured":"Hata H, Imamachi K, Ueda M, Matsuzaka M, Hiraga H, Osanai T, Harabayashi T, Fujimoto K, Oizumi S, Takahashi M, Yoshikawa K, Sato J, Yamazaki Y, Kitagawa Y (2022) Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study. Support Care Cancer 30:4505\u20134514. https:\/\/doi.org\/10.1007\/s00520-022-06839-4","journal-title":"Support Care Cancer"},{"key":"7434_CR2","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ, Panel members (2011) Strategies for subtypes\u2014dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22:1736\u20131747. https:\/\/doi.org\/10.1093\/annonc\/mdr304","journal-title":"Ann Oncol"},{"key":"7434_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10549-010-1113-7","volume":"126","author":"S Dawood","year":"2011","unstructured":"Dawood S, Hu R, Homes MD, Collins LC, Schnitt SJ, Connolly J, Colditz GA, Tamimi RM (2011) Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study. Breast Cancer Res Treat 126:185\u2013192. https:\/\/doi.org\/10.1007\/s10549-010-1113-7","journal-title":"Breast Cancer Res Treat"},{"key":"7434_CR4","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1186\/s12885-016-2766-3","volume":"16","author":"A Hennigs","year":"2016","unstructured":"Hennigs A, Riedel F, Gondos A, Sinn P, Schirmacher P, Marme F, Jager D, Kauczor HU, Stieber A, Lindel K, Debus J, Golatta M, Schutz F, Sohn C, Heil J, Schneeweiss A (2016) Prognosis of breast cancer molecular subtypes in routine clinical care: a large prospective cohort study. BMC Cancer 16:734. https:\/\/doi.org\/10.1186\/s12885-016-2766-3","journal-title":"BMC Cancer"},{"key":"7434_CR5","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S1470-2045(19)30082-8","volume":"20","author":"K Fizazi","year":"2019","unstructured":"Fizazi K, Tran N, Fein L, Matsubara N, Rodriguez-Antolin A, Alekseev BY, Ozguroglu M, Ye D, Feyerabend S, Protheroe A, Sulur G, Luna Y, Li S, Mundle S, Chi KN (2019) Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial. Lancet Oncol 20:686\u2013700. https:\/\/doi.org\/10.1016\/S1470-2045(19)30082-8","journal-title":"Lancet Oncol"},{"key":"7434_CR6","doi-asserted-by":"publisher","first-page":"4762","DOI":"10.3390\/jcm10204762","volume":"10","author":"A Marciano","year":"2021","unstructured":"Marciano A, Ingrasciotta Y, Isgro V, L\u2019Abbate L, Foti SS, Picone A, Peditto M, Guzzo GM, Alibrandi A, Oteri G (2021) Cancer patients at risk for medication-related osteonecrosis of the jaw. A case and control study analyzing predictors of MRONJ onset. J Clin Med 10:4762. https:\/\/doi.org\/10.3390\/jcm10204762","journal-title":"J Clin Med"},{"key":"7434_CR7","doi-asserted-by":"publisher","first-page":"5847429","DOI":"10.1155\/2020\/5847429","volume":"2020","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Yu Y, Shi Y, Li M, Yang C, Wang S (2020) Combined administration of bisphosphonates, chemotherapeutic agents, and\/or targeted drugs increases the risk for stage 3 medication-related osteonecrosis of the jaw: a 4-year retrospective study. Biomed Res Int 2020:5847429. https:\/\/doi.org\/10.1155\/2020\/5847429","journal-title":"Biomed Res Int"},{"key":"7434_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3390\/medicina57050463","volume":"57","author":"S Otto","year":"2021","unstructured":"Otto S, Aljohani S, Fliefel R, Ecke S, Ristow O, Burian E, Troeltzsch M, Pautke C, Ehrenfeld M (2021) Infection as an important factor in medication-related osteonecrosis of the jaw (MRONJ). Medicina (Kaunas) 57:463. https:\/\/doi.org\/10.3390\/medicina57050463","journal-title":"Medicina (Kaunas)"},{"key":"7434_CR9","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1200\/JCO.2008.16.2768","volume":"26","author":"A Kyrgidis","year":"2008","unstructured":"Kyrgidis A, Vahtsevanos K, Koloutsos G, Andreadis C, Boukovinas I, Teleioudis Z, Patrikidou A, Triaridis S (2008) Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients. J Clin Oncol 26:4634\u20134638. https:\/\/doi.org\/10.1200\/JCO.2008.16.2768","journal-title":"J Clin Oncol"},{"key":"7434_CR10","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","volume":"27","author":"K Vahtsevanos","year":"2009","unstructured":"Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis CG, Boukovinas I, Koloutsos GE, Teleioudis Z, Kitikidou K, Paraskevopoulos P, Zervas K, Antoniades K (2009) Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol 27:5356\u20135362. https:\/\/doi.org\/10.1200\/JCO.2009.21.9584","journal-title":"J Clin Oncol"},{"key":"7434_CR11","doi-asserted-by":"publisher","DOI":"10.32388\/IKLIWH","author":"M Cabras","year":"2021","unstructured":"Cabras M, Gambino A, Conrotto D, Garrone M, Fasciolo A, Basano L, Gilardetti M, Galassi C, Fusco V (2021) Survival of metastatic cancer and myeloma patients after diagnosis of osteonecrosis of jaws (ONJ). Potential impact on ONJ treatment strategies. Qeios. https:\/\/doi.org\/10.32388\/IKLIWH","journal-title":"Qeios"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07434-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-07434-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07434-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:25:07Z","timestamp":1669901107000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-07434-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7434"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-07434-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"assertion":[{"value":"24 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed on human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This single-center, retrospective, observational study protocol and patient information were approved by the Hokkaido Cancer Center Hospital Ethics Review Board (clinical study number 02\u201310), and informed consent was waived by this board because of the retrospective design of the study. Permission to access raw data from hospital cancer registries for life prognosis survey was also granted by the ethics review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was waived by the Hokkaido Cancer Center Hospital Ethics Review Board because of the retrospective design of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}